about
Drug-induced liver injury: present and futureStem Cell Strategies to Evaluate Idiosyncratic Drug-induced Liver InjuryPharmacogenetic & pharmacokinetic biomarker for efavirenz based ARV and rifampicin based anti-TB drug induced liver injury in TB-HIV infected patientsTranslating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps)Liver enzyme abnormalities and associated risk factors in HIV patients on efavirenz-based HAART with or without tuberculosis co-infection in TanzaniaThe incidence of liver injury in Uyghur patients treated for TB in Xinjiang Uyghur autonomous region, China, and its association with hepatic enzyme polymorphisms nat2, cyp2e1, gstm1 and gstt1Predose and Postdose Blood Gene Expression Profiles Identify the Individuals Susceptible to Acetaminophen-Induced Liver Injury in RatsPatient-specific hepatocyte-like cells derived from induced pluripotent stem cells model pazopanib-mediated hepatotoxicityDrug-induced liver injury: recent advances in diagnosis and risk assessment.Relationships Between Pharmacovigilance, Molecular, Structural, and Pathway Data: Revealing Mechanisms for Immune-Mediated Drug-Induced Liver Injury.Superoxide Dismutase Gene (SOD1, SOD2, and SOD3) Polymorphisms and Antituberculosis Drug-induced Hepatitis.Metabolic activation and analgesic effect of flupirtine in healthy subjects, influence of the polymorphic NAT2, UGT1A1 and GSTP1.Evaluation of patterns of liver toxicity in patients on antiretroviral and anti-tuberculosis drugs: a prospective four arm observational study in ethiopian patients.Drug-induced liver injury: the dawn of biomarkers?A case of cholestatic hepatitis associated with histologic features of acute cholangitis.Nuclear receptor variants in liver disease.Role of biotransformation in drug-induced toxicity: influence of intra- and inter-species differences in drug metabolism.Immunosuppressant therapy successfully improved regorafenib-induced severe hepatic injury in a patient with metastatic gastrointestinal stromal tumor: A case report.Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.HLA-DQ B1*0201 and A1*0102 Alleles Are Not Responsible for Antituberculosis Drug-Induced Hepatotoxicity Risk in Spanish Population.Clinical characteristics of drug-induced liver injury and related risk factors.Idiosyncratic Drug-Induced Liver Injury (IDILI): Potential Mechanisms and Predictive Assays.An Update on Drug-induced Liver Injury.Drug-induced Liver Injury Associated with Mosapride Citrate: A Report of Two Cases.Genetic variations of bile salt transporters as predisposing factors for drug-induced cholestasis, intrahepatic cholestasis of pregnancy and therapeutic response of viral hepatitis.Drug-induced autoimmune-like hepatitis.Transporter-mediated drug uptake and efflux: important determinants of adverse drug reactions.Assessment of nonsteroidal anti-inflammatory drug-induced hepatotoxicity.Perspectives on epigenetics and its relevance to adverse drug reactions.Review article: Drug-induced liver injury--its pathophysiology and evolving diagnostic tools.Pharmacogenetics of drug transporters in the enterohepatic circulation.Transporter-mediated drug-drug interactions.Central role of mitochondria in drug-induced liver injury.Latest advances in predicting DILI in human subjects: focus on biomarkers.Genetic risk factors for drug-induced liver injury in rheumatoid arthritis patients using low-dose methotrexate.Utilization of glutathione S-transferase Mu 1- and Theta 1-null mice as animal models for absorption, distribution, metabolism, excretion and toxicity studies.Hepatotoxicity of tyrosine kinase inhibitors: clinical and regulatory perspectives.Intrahepatic cholestasis in common chronic liver diseases.Idiosyncratic drug-induced liver injury: an update on the 2007 overview.Toward predictive models for drug-induced liver injury in humans: are we there yet?
P2860
Q24630227-A2695B46-B8EF-4E74-9EB5-6CFFB9AE3440Q26781923-0E70F23F-E031-49E0-A01D-4A46796662A6Q28478275-9BDA6768-4799-43E6-B47E-4BFF5D75082DQ28478443-41C314F8-C1B7-4CFB-970C-F0C1E0586B2EQ28481272-4DD612F4-D9A3-40EF-B425-BB10E21AB62AQ28539060-F9E99F36-91DB-42F9-B0EB-332E7ED19A5AQ28550555-3B6D81DD-631B-43B3-B117-76BC6F765E25Q29247916-CA7BF88C-8BC4-4F4F-AB1C-A3E0F3B15FA6Q30235089-CA6CE0CB-7D39-48AA-B56B-40ABD6F5C233Q30990061-24B68C3D-4F1F-4D81-A37D-AB73986DD9DAQ34760618-9CEFB5F9-3073-4A5D-8CB6-9F317E372087Q35135974-81CD3FD9-0D6F-4770-8BA6-C6DD0876C2CEQ35142786-AB6543EF-4065-445E-9D44-4EC67B8901ACQ35210890-6AF22D30-8980-46E7-A312-1BFDFD794594Q35599972-93E7403E-63F6-4CFB-B6DC-5F7B5BE75EE9Q35864839-846B82CD-6859-4ACC-8380-6402AF5E91CEQ36362377-6D62EE3F-DC6D-4F1F-949A-0FEC9044CF25Q36503222-80D87C71-4BBD-4F56-8927-44B1C0B30858Q37121662-D6A04EDA-745D-451B-9FD1-10F419F53A3EQ37193472-4EC6A4F3-C938-4C7C-B09E-266B8A35F1B7Q37289416-1A74D7E1-5225-43DB-AF8D-0A944F923CB9Q37590883-6FDD4C3B-BB3B-4B6B-B3B5-79508B78AFDFQ37613520-1A9F9F20-0503-4738-ADB4-31E8D2288BD2Q37647432-C066527E-909E-4C2E-9B03-944A09EE2AF8Q37841614-AE5BA736-67EA-425A-AD4F-7B3D64CC3BB7Q37843783-BC1C58C3-0537-41CE-BE51-8695214D6DD4Q37862576-361A46FF-0BCA-445F-A5D1-46C09E3D1E37Q37862739-AF9FE853-CB3A-44EA-8D7A-1EA07833FAE7Q37867482-9D75C932-07D7-46FC-9491-B5C8326016AFQ37871623-B1D0165F-3CEE-4750-ADE0-98C382E1A1ADQ37880875-9ED9C8A4-BB42-4A1C-B982-74DB8DEB2F3FQ37905033-F4B1E649-FAC1-4A19-A7E1-B4C41469EA88Q37926590-B87590CA-9556-42B4-8108-3AC0CCB42258Q38045377-D204AD72-8AA7-4D0E-988B-1812DB89496CQ38068540-8ABF67A6-F91E-44A6-896A-580533616C89Q38090712-E591F8B9-136E-42B3-B45B-759D3E2F2BFCQ38101884-D2DC9614-6222-40B3-B979-BA6CC7F814C3Q38127461-B4414CB4-CF7D-44F5-B356-C902201E6F54Q38145274-E38EE97E-08CD-47DC-9509-B830DA3903B1Q38187450-5B59FC56-C318-47DA-8A5A-30780362ADDB
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacogenetics of drug-induced liver injury.
@en
Pharmacogenetics of drug-induced liver injury.
@nl
type
label
Pharmacogenetics of drug-induced liver injury.
@en
Pharmacogenetics of drug-induced liver injury.
@nl
prefLabel
Pharmacogenetics of drug-induced liver injury.
@en
Pharmacogenetics of drug-induced liver injury.
@nl
P2093
P2860
P356
P1433
P1476
Pharmacogenetics of drug-induced liver injury.
@en
P2093
Alexander Jetter
Gerd A Kullak-Ublick
Stefan Russmann
P2860
P304
P356
10.1002/HEP.23720
P407
P577
2010-08-01T00:00:00Z